Bank of Montreal’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,116
Closed -$376K 4381
2022
Q1
$376K Sell
11,116
-1,485
-12% -$41.3K ﹤0.01% 3050
2021
Q4
$416K Sell
12,601
-10,784
-46% -$367K ﹤0.01% 2529
2021
Q3
$1.02M Sell
23,385
-985
-4% -$35.4K ﹤0.01% 2482
2021
Q2
$943K Buy
24,370
+7,884
+48% +$282K ﹤0.01% 2520
2021
Q1
$581K Buy
16,486
+934
+6% +$39.8K ﹤0.01% 2551
2020
Q4
$749K Sell
15,552
-38,023
-71% -$1.33M ﹤0.01% 2459
2020
Q3
$1.48M Sell
53,575
-7,513
-12% -$245K ﹤0.01% 1796
2020
Q2
$2.34M Sell
61,088
-2,039
-3% -$76K ﹤0.01% 1566
2020
Q1
$1.86M Sell
63,127
-27,051
-30% -$1.13M ﹤0.01% 1454
2019
Q4
$3.69M Buy
90,178
+21,885
+32% +$865K ﹤0.01% 1531
2019
Q3
$2.43M Buy
68,293
+5,825
+9% +$236K ﹤0.01% 1551
2019
Q2
$3.21M Buy
62,468
+3,422
+6% +$171K ﹤0.01% 1427
2019
Q1
$3.38M Buy
59,046
+3,485
+6% +$173K ﹤0.01% 1376
2018
Q4
$2.33M Sell
55,561
-4,843
-8% -$284K ﹤0.01% 1448
2018
Q3
$4.56M Buy
60,404
+22,606
+60% +$1.63M ﹤0.01% 1245
2018
Q2
$2.71M Buy
37,798
+35,914
+1,906% +$1.72M ﹤0.01% 1481
2018
Q1
$56K Sell
1,884
-500
-21% -$14.6K ﹤0.01% 3191
2017
Q4
$79K Sell
2,384
-49,616
-95% -$1.49M ﹤0.01% 3096
2017
Q3
$1.71M Buy
+52,000
New +$1.17M ﹤0.01% 1692

Other funds holding RGNX

Bank of Montreal's RGNX Position: Q2 2022 in Review

Bank of Montreal sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 11,116 shares — an estimated $376K sold.

Bank of Montreal first reported a position in RGNX in Q3 2017 and held it in 19 quarters. The position peaked at $4.56M in Q3 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • Bank of Montreal reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 11,116 Regenxbio shares in Q2 2022, an estimated $376K.
  • Bank of Montreal first reported a position in Regenxbio in Q3 2017 and held it in 19 quarters.
  • Bank of Montreal's Regenxbio position peaked at $4.56M in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.